Sotera Health Co Aktie News

Q2 2026 Nettoumsatz stieg um 9,2 % bzw. um 8,0 % auf konstanter Währungsbasis (1) im Vergleich zu Q2 2025 Q2 2026 Nettogewinn von 54 Mio. USD bzw. 0,19 USD je verwässerter Aktie, verglichen mit einem Nettogewinn von 8 Mio. USD bzw. 0,03 USD je verwässerter Aktie in Q2 2025 Q2 2026 Adjusted EBITDA (1) stieg um 10,0 %, bzw. um 8,7 % auf konstanter Währungsbasis Q2 2026 Adjusted EPS (1) von 0,26 U...

CLEVELAND, May 11, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 31,838,253 shares of its common stock, par value $0.01 per share. All 31,838,253 shares are being offered for sale by certain affiliates of Warburg Pincus LLC (“Warburg Pincus”) and GTCR LLC (“GTCR”) as selling stockholders.

Q1 2026 net revenues increased 10.0%, or 6.5% on a co nstant currenc y basis, compared to Q1 2025 Q1 2026 net income of $27 million or $0.09 per diluted share, compared to a net loss of $13 million or $0.05 per diluted share in Q1 2025 Q1 2026 Adjusted EBITDA ( 1 ) increased 10.5%, or 6.9% on a constant currency basis Q1 2026 Adjusted EPS (1) of $0.18 , an increase of 29% per diluted share Comp...

Alton Shader, CEO of Viant Medical®, to become CEO and join the Board of Directors, effective May 26, 2026 Chairman and CEO Michael B. Petras, Jr. will serve as Executive Chairman of the Board of Directors CLEVELAND, May 05, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solu...

CLEVELAND, April 21, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the first-quarter ended March 31, 2026 before the market opens on Tuesday, May 5, 2026. Following the rele...

Sessa Capital increased its Sotera Health holding by 10,630,381 shares in the fourth quarter. The quarter-end position value rose by $206.47 million, reflecting both the share addition and stock price movement.

Inherent Management Corp. purchased 200,050 shares of Sotera Health in the fourth quarter. The quarter-end Sotera Health position value increased by $5.39 million as a result of the purchase.